Grattoni lab

Seeking highly motivated #phdstudents #mdphdstudent & aspiring #postdocjobs to continue advances in controlled #drugdelivery! DM us if you are interested or email agrattoni@houstonmethodist.org and ychua@houstonmethodist.org @tamu @weillcornell @tecdemonterrey #medicaldevices

Good news! My article received enough views to be a Top Viewed Article. Read it here onlinelibrary.wiley.com/doi/full/10.10… #TopViewedArticle @wileyinresearch

This week we had the pleasure to host Dr. Twan Lammers @twan_lammers for a lecture at the Nanomedicine Seminar Series. Thank you for enlightening us with your research! @CRSScience

Had the privilege to present at #crsingapore last week. It was such a well organized meeting worth brilliant scientists from across the world. Would love for this to be a yearly event! @CRSScience

Honored to have Dr. Arum Han @NanoBioTAMU speak at our Annual Nanomedicine Symposium today. We finally got to meet in person for the first time! It was great hearing about MPS and its applicability in fetal maternal medicine and other fields, among his other research areas.

We are honored to have Paolo Decuzzi @pgdecuzzi from the Italian Institute of Technology @IITalk give a talk at the Dept of Nanomedicine Seminar today. He was our former colleague at @HMethodistMD over a decade ago. Happy to have you back even though it was a brief visit!

Continuity Biosciences launches to enable breakthrough therapies with innovative delivery technologies from Houston @MethodistHosp. @HMethodistMD Alessandro @GrattoniLab, a leader in advanced drug delivery, is the Chief Scientific Advisor. firstwordpharma.com/story/5912023

Honored to attend the Nancy Owens Breast Cancer Foundation luncheon today. Meeting the inspiring women and advocates for the fight against breast cancer is incredibly inspiring for our research. Thank you @nobcf_houston!

A novel refillable antiretroviral drug implant was found to be safe and capable of delivering one or more drugs. The implant is being studied for delivery of #HIV pre-exposure prophylaxis and #AntiretroviralTherapy. Learn more: programme2024.hivr4p.org/Abstract/Abstr… #HIVR4P2024

@GrattoniLab’s refillable subdermal implants (under development) will be capable of: • Sustainably delivering antiretrovirals (ISL, MK8527, BIC, LEN & DTG) for HIV prevention upto 8 years (based on the dose loaded)! • Co-delivering with hormonal contraceptives #HIVR4P2024

Excited to be part of the panel at the #HIVR4P2024 press conference to share our latest development on implantable systems for HIV prevention with the press and media. Hopefully our technology will soon provide an alternative PrEP option for people at risk of HIV. @iasociety #hiv

I’m excited to be at #HIVR4P2024, the only global scientific conference focused exclusively on HIV prevention. Join me at the press conference Monday AM and my talk on our drug agnostic implant for HIV PrEP on Wed October 9 in person and online. @iasociety @USAID @PEPFAR

A food dye in Cheetos can be used to make mice transparent at your site of interest. Imagine the possibilities! We can’t wait to try this out for our research.

Global experts help nanomedicines DELIVER on healthcare promise @NatureNano.DELIVER guidelines present early-stage recommendations for nanomedicine development during design, experiment, manufacturing, preclinical, clinical, regulatory, and business. nature.com/articles/s4156… 👏🥳

In a study in @Nature, researchers demonstrate the role of sex hormones in regulating the immune system. This knowledge explains differences between men and women and can be used to develop new immunological medications. Research by @BrodinPetter et al. news.ki.se/new-research-e…

A review that is not to be missed! 🙌 Drs. Alessandro Grattoni (@GrattoniLab), Mark Poznansky, Paul de Vos, and collaborators at @BreakthroughT1D map the progress in cell replacement therapies for type 1 #diabetes. 📰: @NatureRevEndo | go.nature.com/3My2Zh2

Sharing our review on cell therapies for type 1 diabetes, highlighting replenishable cell sources, delivery strategies and immune protection, among others. Excited to collaborate with coauthors who are continuing to make an impact in the field @NatureRevEndo @BreakthroughT1D

If you’re at #crs2024, please join us at Nikita’s presentation at the Immuno Delivery II session today July 11th at 3:30pm.

We hope this review will be useful for anyone interested in space biomaterials/biomanufacturing. Honored to work together with leaders in these fields, including @GrattoniLab @CliveSvendsen Bob Langer @cgtraverso @mit William Wagner @McGowanRM Ray Lugo @ISS_CASIS!

🚀 Authors at the @GrattoniLab, including Drs. Corrine Ying Xuan Chua and @ArunSharmaPhD, explore the use of material technologies for delivery of space medicine in the context of health maintenance and preventive care, including emergency treatment. go.nature.com/45dGmqz

Researchers of @GrattoniLab have developed a nanodevice that administers immunotherapy drugs directly into pancreatic ductal adenocarcinomas. Read more on Leading Medicine: spr.ly/6017nkGvc